Journal Report

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Download PDF
Journal Information
Journal Title
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
Publisher
WILEY
ISSN
1743-7555
E-ISSN
1743-7563
Database
Clarivate
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Divergent Trends in Head and Neck Cancer Burden in China (1990–2021)
Ming Tang, Kaitai Liu, Zhuo Wu et al.
2026-10-31
DOI: 10.1111/ajco.70161
Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment
Tamotsu Sagawa, Masahiro Hirakawa, Hiroyuki Nagashima et al.
2026-10-30
DOI: 10.1111/ajco.70220
Opioid Prescribing Changes in Advanced Cancer Before and After Withdrawal of Hydromorphone Slow‐Release Tablets
Aaron K. Wong, Helen McManus, Sara Vogrin et al.
2026-10-24
DOI: 10.1111/ajco.70216
Re: “Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer.”
Gharbi Lassad
2026-10-24
DOI: 10.1111/ajco.70219
Global Burden and Trends of Early‐Onset Tracheal, Bronchus, and Lung Cancer Among Women From 1990 to 2021
Liang Zhang, Hailong Wang, Gaofeng Liang et al.
2026-10-22
DOI: 10.1111/ajco.70212
Issue Information
2026-10-22 Vol. 22 Issue 6 Pages 773-774
DOI: 10.1111/ajco.70205
Response Letter: Re: “Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer”
Tracy R. Fitzsimmons, Bunjo Zachary, Sammour Tarik
2026-10-22
DOI: 10.1111/ajco.70217
Emerging Roles of Gold Nanoparticles in Lung Cancer Diagnosis and Imaging: A Promising yet Underexplored Frontier
Satvika Sharma, Vijayta Dani Chadha
2026-10-22
DOI: 10.1111/ajco.70215
Hyaluronan‐Mediated Motility Receptor Potentiates Colorectal Carcinoma Progression Through PI3K/AKT/mTOR Pathway Modulation
Cheng Shi, Yu Chen, Xinyu Hu et al.
2026-10-22
DOI: 10.1111/ajco.70200
Minimum 7‐Year Follow‐Up of a Prospective Phase II Trial of Preoperative S‐1 Plus Oxaliplatin Chemotherapy for Clinical Stage III Gastric Cancer
Sayuri Konishi, Dai Manaka, Yuji Yoshida et al.
2026-10-18
DOI: 10.1111/ajco.70214
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 1, 2026 22:45